Malignant neoplasm of testis, including Hilmo

C3_TESTIS_WIDE

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

only males

244368

2. Check conditions

None

244368

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C62
  • Hospital discharge: ICD-9 186
  • Hospital discharge: ICD-8 186
  • Cause of death: ICD-10 C62
  • Cause of death: ICD-9 186
  • Cause of death: ICD-8 186
  • Cancer registry: Topography ICD-O-3 C62
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

793

4. Check minimum number of events

None

793

5. Include endpoints

None

793

6. Filter based on genotype QC (FinnGen only)

709

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

List of similar endpoints to Malignant neoplasm of testis, including Hilmo based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 709 - 709
Unadjusted period prevalence (%) 0.33 - 0.33
Median age at first event (years) 37.35 - 37.35

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
746
Matched controls
7460
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
313.3
278
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
683.0
307.7
499
22
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
586.5
307.7
416
16
JN4BD
NOMESCO Finland
Extensive body CT
30.0
307.7
273
141
A03FA01
ATC
metoclopramide; systemic, rectal
17.4
295.6
293
267
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
256.5
231
*
130
Kela drug reimbursment
Malignant tumour
+∞
255.3
230
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
17.1
224.0
208
165
H02AB02
ATC
dexamethasone; systemic
49.4
210.1
124
30
JN4AD
NOMESCO Finland
Body CT examination
15.5
209.7
206
179
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
193.4
177
*
A04AA01
ATC
ondansetron; systemic, rectal
30.8
167.5
113
43
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
146.8
136
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
123.4
115
*
A04AA02
ATC
granisetron; systemic, transdermal
1218.2
110.4
105
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
104.7
98
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
32.3
99.2
65
22
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
176.7
90.4
93
6
L03AA02
ATC
filgrastim; parenteral
204.3
88.4
90
5
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
85.1
80
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
85.1
80
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
84.0
79
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
81.8
77
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
80.7
76
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
79.6
75
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
387.9
72.0
71
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
66.7
63
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
124.5
64.0
68
6
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
62.4
59
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
229.0
62.1
63
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
61.6
436
2140
WZC00
NOMESCO Finland
Treatment plan or consultation
3.5
59.1
326
1365
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
57.0
54
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.5
56.6
122
256
XX3DW
NOMESCO Finland
Time consuming IT work
7.9
56.1
81
113
L03AA13
ATC
pegfilgrastim; parenteral
578.9
55.3
54
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
54.9
52
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
54.9
52
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
567.3
54.2
53
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
51.7
49
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.3
51.1
154
424
N02AA05
ATC
oxycodone; systemic
4.5
51.0
145
382
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
48.5
46
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
244.7
45.5
46
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
45.3
43
*
WF002
NOMESCO Finland
Radical radiotherapy
464.2
44.7
44
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
44.2
42
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
441.6
42.6
42
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
42.1
40
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
42.1
40
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
41.0
39
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
41.0
39
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
55.6
40.0
47
9
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
40.0
38
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.0
39.2
126
360
WW500
NOMESCO Finland
Blood transfusion
11.1
37.8
41
39
116
Kela drug reimbursment
Prostate cancer
+∞
37.8
36
*
Z51.5
ICD-10 Finland
Palliative care
7.4
37.4
56
81
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
35.8
132
414
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
35.7
34
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
363.6
35.3
35
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
34.6
33
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
34.4
221
961
JN4CD
NOMESCO Finland
Very extensive body CT
12.7
34.3
34
28
B01AB10
ATC
tinzaparin; parenteral
4.7
33.9
83
192
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
33.6
32
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
33.6
32
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.4
33.4
50
72
E29.1
ICD-10 Finland
Testicular hypofunction
6.3
32.9
57
96
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
31.5
30
*
ZXE00
NOMESCO Finland
One hour or less
2.5
31.4
290
1499
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
30.4
29
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
30.4
29
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.7
30.0
43
59
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
5.1
29.8
65
136
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
29.4
28
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
29.4
28
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
28.3
27
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
26.2
25
*
Y05
ICPC
Scrotum/testis sympt/compl other
6.5
25.6
43
70
XW000
NOMESCO Finland
Bone marrow biopsy
8.6
25.4
33
40
WX402
NOMESCO Finland
General anaesthesia
2.6
25.3
176
784
L01BC06
ATC
capecitabine; oral
+∞
25.1
24
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.3
24.3
50
99
Y78
ICPC
Malign neopl male genital other
+∞
24.1
23
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
247.6
23.8
24
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
23.0
99
338
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
23.0
22
*
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
23.0
22
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
23.0
247
1331
ZX120
NOMESCO Finland
Intravenous
3.7
22.7
76
221
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
22.0
21
*
WX320
NOMESCO Finland
Spinalanesthesy
2.5
21.7
168
782
A04AD12
ATC
aprepitant; systemic
+∞
20.9
20
*
B01AB05
ATC
enoxaparin; parenteral
2.4
20.5
181
892
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
20.1
244
1370
D29.2
ICD-10 Finland
Benign neoplasm: Testis
36.9
19.9
25
7
L02BB03
ATC
bicalutamide; oral
+∞
19.9
19
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
19.9
19
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
19.9
19
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.9
19.3
30
45
KF8AE, ,
SPAT
5.1
19.2
41
84
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
18.8
18
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
18.8
18
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
18.8
18
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.7
18.8
62
178
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
194.7
18.6
19
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
68.3
17.8
20
*
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
17.8
17
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
17.8
17
*
DFF00
NOMESCO Finland
Pure tone audiometry
2.9
17.7
87
320
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
184.2
17.6
18
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.0
17.5
27
40
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
7.1
17.1
26
38
N02BE01
ATC
paracetamol; systemic, rectal
2.4
17.0
627
5144
JN6AD
NOMESCO Finland
CT of torso and neck
22.5
16.9
24
11
WZC30
NOMESCO Finland
Teaching
2.5
16.9
114
494
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
16.7
16
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
5.9
16.4
30
53
N46
ICD-10 Finland
Male infertility
4.2
16.2
44
110
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
15.7
15
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
15.7
15
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
87.0
15.6
17
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
163.3
15.5
16
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
15.2
119
550
N50.9
ICD-10 Finland
Disorder of male genital organs, unspecified
6.7
15.0
24
37
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
14.6
14
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
14.6
14
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
14.6
14
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
81.8
14.6
16
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.4
14.6
111
507
5703
FHL
Removal of lymph nodes from the retroperitoneal space
152.9
14.5
15
*
N05BA06
ATC
lorazepam; systemic, sublingual
3.4
13.7
51
159
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.9
13.6
40
106
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
13.6
13
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
13.6
13
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
13.6
13
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
13.6
13
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
13.6
13
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
13.6
13
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
13.6
13
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.5
13.2
32
73
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
13.1
157
860
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
12.5
12
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
12.5
12
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
12.5
12
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
12.5
12
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.1
12.5
34
85
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
38.2
12.2
15
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.7
12.2
28
61
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
12.1
73
298
7513
FHL
Test prosthesis installation
47.5
11.9
14
*
R50.9
ICD-10 Finland
Fever, unspecified
2.1
11.8
123
637
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.8
11.5
21
37
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
11.5
11
*
Y77
ICPC
Malignant neoplasm prostate
121.8
11.5
12
*
A79
ICPC
Malignancy NOS
121.8
11.5
12
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
11.4
72
301
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
11.4
123
646
M04AA01
ATC
allopurinol; systemic
2.2
11.1
102
503
B01AB04
ATC
dalteparin; parenteral
4.0
10.9
31
80
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.5
10.8
38
114
N02AX02
ATC
tramadol; systemic, rectal
1.7
10.8
278
1921
KFC10
NOMESCO Finland
Bilateral orchiectomy
60.9
10.6
12
*
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
+∞
10.4
10
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.4
10
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
10.4
10
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
10.4
10
*
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
4.4
10.4
26
61
KFA00
NOMESCO Finland
Exploration of testis
9.0
10.3
21
24
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.6
10.2
23
31
A02BC02
ATC
pantoprazole; systemic
1.7
10.2
424
3302
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.1
10.2
44
150
J01MA02
ATC
ciprofloxacin; systemic
1.7
9.9
243
1650
KFB00
NOMESCO Finland
Biopsy of testis
20.3
9.8
14
7
ZXA05
NOMESCO Finland
Left side
1.9
9.5
146
862
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
9.4
9
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
9.4
9
*
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
+∞
9.4
9
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
9.4
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.4
9
*
J01MA12
ATC
levofloxacin; systemic
2.0
9.4
109
586
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.1
9.3
25
62
WX702
NOMESCO Finland
Supraglottic ventilation device
2.9
9.3
43
153
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
8.9
127
731
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
24.3
8.9
12
5
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.1
8.8
24
60
GD1AD
NOMESCO Finland
Thorax CT examination
2.8
8.8
45
169
Y28
ICPC
Limited function/disability (Y)
9.1
8.6
17
19
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
7.5
8.5
19
26
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
91.1
8.4
9
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
91.1
8.4
9
*
1860A
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOPL MAL TESTIS (ABDOMIN/INGUIN),SEMINOMA]
+∞
8.3
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.3
8
*
9061/3-C62.0
ICD-O-3
Seminoma, NOS, of undescended testis
+∞
8.3
8
*
1869C
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),MUU TAI TARK MÄÄRITT]
+∞
8.3
8
*
KFC96
NOMESCO Finland
Other total excision of testis or epididymis
+∞
8.3
8
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
8.3
8
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
8.3
8
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.4
8.2
58
255
KA1FN
NOMESCO Finland
Isotope renography
14.7
8.2
13
9
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.7
8.2
18
24
Z31.8
ICD-10 Finland
Other procreative management
33.7
8.1
10
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
17.4
8.1
12
7
R4190
NOMESCO Finland
Nutritional therapy
3.6
8.0
26
74
H02AB07
ATC
prednisone; oral
2.1
7.9
77
388
R4110
NOMESCO Finland
Physiotherapy
1.7
7.7
162
1044
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.3
7.6
60
277
Z3231
NOMESCO Finland
Registered nurse
1.7
7.5
167
1092
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
7.5
65
312
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.2
7.5
17
24
A41.9
ICD-10 Finland
Sepsis, unspecified
3.1
7.5
30
98
ZXA00
NOMESCO Finland
Right side
1.7
7.5
150
954
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
80.9
7.4
8
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
7.8
7.4
16
21
KCD02
NOMESCO Finland
Transurethral resection of bladder
13.5
7.4
12
9
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
7.3
7
*
L02AE03
ATC
goserelin; implant
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
7.3
7
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
7.3
7
*
1860B
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOP MAL TEST (ABD/ING),CA EMBR/TERATOCA/CHORIOCA]
+∞
7.3
7
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
UKC02
NOMESCO Finland
Cystoscopy
1.9
7.3
95
531
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
7.1
65
320
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
10.2
7.1
13
13
UJF32
NOMESCO Finland
Coloscopy
1.7
7.0
138
873
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.2
6.8
17
28
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
40.4
6.8
8
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
40.4
6.8
8
*
KFD43
NOMESCO Finland
Unilateral vasectomy or ligature of vas deferens
40.4
6.8
8
*
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
16.9
6.8
10
6
JAH01
NOMESCO Finland
Laparoscopy
4.0
6.7
19
49
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.8
6.6
32
117
C03CA01
ATC
furosemide; systemic
1.6
6.6
154
1018
ZXD05
NOMESCO Finland
Urgent procedure
1.6
6.6
183
1263
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.8
6.6
13
15
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
6.5
40
166
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
70.4
6.4
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
70.4
6.4
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
70.4
6.4
7
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
70.4
6.4
7
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
7.5
6.4
14
19
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
6.4
53
250
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
6.3
6
*
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
+∞
6.3
6
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
6.3
6
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
L02BB01
ATC
flutamide; oral
+∞
6.3
6
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
9680/3-C62.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of descended testis
+∞
6.3
6
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
6.3
6
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.0
6.2
17
43
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
6.1
104
631

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
192
14
184.33
307.65
10.8
1.1
497.45
—
pmol/l
—
127
0
196
150
17.37
214.95
1.2
1.3
—
—
—
0
0
167
113
18.75
194.85
3.6
1.4
16.09
7.33
iu/l
5.62
126
86
218
266
11.17
175.21
3.2
1.5
7.80
4.15
u/l
6.46
176
218
343
1171
4.57
90.72
4.7
2.5
13.27
15.48
nmol/l
7.17
331
1095
520
2611
4.27
76.22
10.9
4.7
11.05
13.30
umol/l
4.52
515
2494
214
604
4.57
70.42
1.4
1.7
—
—
—
0
0
245
904
3.55
53.44
1.6
1.7
—
—
—
0
0
326
1435
3.26
53.27
2.1
1.6
—
—
—
0
0
238
905
3.39
48.93
1.7
1.8
—
—
—
0
0
617
4096
3.93
47.58
13.8
6.4
78.79
75.77
u/l
0.80
610
3889
508
3047
3.09
45.56
13.9
8.8
3.74
4.26
e9/l
4.79
457
2646
308
1428
2.97
44.26
5.5
2.1
2.36
2.35
mmol/l
0.89
286
1280
49
9
58.12
41.98
8.7
2.1
3.63
3.67
ug/l
—
49
9
199
783
3.10
37.47
5.6
2.0
2.44
2.42
mmol/l
2.37
180
688
82
195
4.60
32.32
5.6
2.0
4.01
2.56
ug/l
1.81
66
153
374
2155
2.47
32.14
9.5
4.7
36.25
36.78
g/l
0.93
352
2004
268
1351
2.54
30.43
2.0
2.1
—
—
—
0
0
355
2038
2.42
30.24
3.2
2.6
—
—
estimate
—
0
0
454
2920
2.42
29.65
4.4
3.3
4.20
155.46
e6/l
—
5
41
123
414
3.36
29.58
1.3
1.1
—
—
—
0
0
272
1407
2.47
28.95
1.4
1.3
—
—
—
0
0
259
1319
2.48
28.44
3.5
2.8
—
0.00
estimate
—
0
7
297
1611
2.40
28.32
3.8
3.0
57.38
107.74
e6/l
0.41
231
1215
267
1383
2.45
28.20
3.5
2.9
0.45
0.32
e6/l
0.25
203
992
394
2429
2.32
27.72
10.6
7.3
1.20
1.20
mmol/l
0.33
320
2120
417
2647
2.30
27.19
6.8
7.0
26.62
28.09
%
1.85
402
2541
50
90
5.88
26.96
3.2
6.7
10.26
8.54
%
1.03
50
90
50
90
5.88
26.96
1.6
3.4
41.94
46.01
%
0.62
50
90
403
2538
2.28
26.56
6.8
7.0
2.77
2.99
%
1.16
389
2413
403
2541
2.27
26.45
7.0
7.1
0.71
0.68
%
0.55
389
2421
404
2551
2.27
26.41
7.0
7.1
9.17
9.11
%
0.17
389
2425
317
1814
2.30
26.24
4.3
3.5
40.06
87.26
e6/l
0.93
242
1286
356
2142
2.27
26.07
9.2
7.1
1.21
1.20
mmol/l
0.72
347
1977
386
2432
2.22
24.87
13.4
10.2
0.00
0.00
e9/l
0.68
314
2000
462
3138
2.24
24.55
6.4
5.6
6.64
6.81
mmol/l
0.82
447
3020
401
2609
2.16
23.29
6.6
6.8
57.68
56.73
%
0.82
391
2527
171
802
2.47
21.71
3.5
2.8
0.40
0.59
e6/l
0.55
98
377
256
1431
2.20
21.54
3.2
2.4
—
—
—
0
0
241
1315
2.23
21.53
5.5
4.3
91.16
86.06
%
2.78
235
1294
424
2873
2.10
21.50
6.7
7.0
1.65
1.90
e9/l
7.86
367
2543
415
2800
2.09
21.16
6.6
6.8
0.60
0.61
e9/l
0.35
348
2434
177
857
2.40
20.87
3.3
2.7
0.84
0.89
e6/l
0.05
106
433
414
2801
2.07
20.83
6.6
6.9
0.04
0.04
e9/l
2.20
348
2439
257
1466
2.15
20.33
6.5
4.3
—
—
—
0
0
253
1441
2.14
20.04
3.6
2.5
364.50
377.59
umol/l
1.42
238
1305
418
2877
2.03
19.61
7.0
7.3
0.17
0.20
e9/l
4.24
358
2532
92
336
2.98
18.97
5.7
3.1
1.23
1.22
mmol/l
1.90
87
283
22
5
45.22
18.32
1.0
1.0
—
—
—
0
0
183
945
2.24
18.32
3.3
2.5
589.91
569.73
mosm/kgh2o
0.54
165
816
356
2355
1.98
18.26
16.2
16.0
1.23
1.30
inr
1.40
306
1980
203
1111
2.14
17.46
1.8
1.9
1.17
1.01
mg/l
0.49
153
804
198
1083
2.13
17.00
3.0
2.5
2.90
2.26
e6/l
0.61
179
982
235
1372
2.04
16.93
6.9
3.7
7.40
7.39
ph
0.64
182
967
15
0
+∞
15.68
6.7
0.0
0.33
—
umol/l
—
15
0
246
1540
1.89
13.99
11.1
5.5
—
—
—
0
0
23
37
6.38
13.81
1.3
1.1
—
—
—
0
0
188
1084
1.98
13.61
2.9
2.5
—
—
—
0
0
144
792
2.01
11.76
9.3
8.9
104.51
104.48
mmol/l
0.03
144
792
36
100
3.73
11.47
2.5
3.7
57.17
57.96
%
0.17
36
100
21
38
5.66
11.22
1.4
1.3
—
—
—
0
0
656
5754
2.16
10.86
25.4
15.4
139.50
139.81
mmol/l
3.45
647
5632
656
5778
2.12
10.35
25.9
15.4
4.00
4.01
mmol/l
0.59
645
5647
30
80
3.87
10.13
2.7
4.3
4.00
4.29
e9/l
0.30
30
80
17
14
12.39
9.89
1.2
1.0
—
—
—
0
0
143
831
1.89
9.83
3.4
2.6
12.91
14.25
umol/l
1.37
134
772
652
5791
2.00
9.11
23.3
12.6
24.44
25.62
mg/l
0.40
563
4599
124
715
1.88
8.67
3.7
2.7
24.32
25.36
%
0.37
116
667
17
20
8.67
8.34
1.3
1.5
—
—
—
0
0
131
780
1.82
8.25
3.5
2.6
2.26
2.26
g/l
0.01
122
724
96
527
1.94
7.75
1.9
2.1
—
—
—
0
0
340
2650
1.52
7.18
3.4
3.1
0.01
7.12
estimate
0.80
89
514
63
306
2.16
7.09
10.1
15.6
16.33
16.58
%
0.26
63
296
77
404
2.01
7.07
5.2
3.7
7.38
7.34
ph
2.25
70
304
97
552
1.87
7.02
3.7
2.6
1.72
1.74
%
0.08
88
499
71
364
2.05
6.95
3.5
3.2
—
—
—
0
0
335
2616
1.51
6.93
3.4
3.1
0.00
0.00
estimate
-0.00
90
516
15
20
7.63
6.92
1.1
1.2
—
—
—
0
0
132
838
1.70
6.59
3.1
2.7
—
—
—
0
0
91
520
1.85
6.50
10.9
11.5
—
—
—
0
0
83
462
1.90
6.43
4.3
5.0
1.87
0.70
%
2.04
42
114
76
413
1.94
6.32
2.9
2.4
62.45
67.94
e9/l
0.73
57
296
80
443
1.90
6.29
3.9
4.8
1.08
0.49
%
1.05
39
116
336
2662
1.48
6.29
3.4
3.1
0.00
0.02
estimate
0.79
81
460
562
4943
1.56
6.22
30.4
15.6
13.56
13.33
%
4.11
555
4873
88
508
1.83
6.08
3.5
2.6
31.35
129.61
u/l
0.54
71
438
210
1523
1.53
5.99
3.3
2.6
0.00
0.00
estimate
-0.00
67
393
19
57
3.39
5.47
1.5
1.2
—
—
—
0
0
124
813
1.63
5.43
2.1
2.3
—
—
—
0
0
77
448
1.80
5.20
4.3
5.1
0.33
0.06
%
1.65
36
101
95
588
1.71
5.18
5.7
2.4
12.70
9.37
umol/l
0.41
84
521
28
110
2.61
5.10
1.7
1.4
270.71
289.76
ug/g
0.15
17
62
392
3289
1.40
4.95
4.9
3.6
2.77
1.67
ug/l
0.86
348
3003
112
737
1.61
4.82
1.9
1.5
—
—
—
0
0
19
62
3.12
4.82
2.1
1.7
—
—
—
0
0
19
62
3.12
4.82
2.1
1.7
—
—
—
0
0
19
62
3.12
4.82
2.1
1.7
—
—
—
0
0
19
62
3.12
4.82
2.1
1.7
—
—
—
0
0
77
460
1.75
4.76
4.6
5.3
0.20
0.00
%
1.15
35
95
217
1651
1.44
4.72
3.4
2.7
54.66
61.30
u/l
1.25
201
1559
274
2175
1.41
4.71
3.1
3.0
6.15
6.13
ph
0.15
163
1288
96
619
1.63
4.48
5.3
3.8
7.36
7.38
ph
1.59
71
367
15
44
3.46
4.48
2.5
2.4
0.50
0.80
e9/l
1.96
15
44
259
2057
1.40
4.37
3.4
3.0
0.00
0.00
estimate
0.50
79
434
98
641
1.61
4.32
9.6
10.8
0.74
0.96
mmol/l
0.31
81
524
31
139
2.28
4.30
1.5
1.4
—
—
—
0
0
98
647
1.59
4.16
9.7
10.9
7.41
7.41
ph
0.09
48
364
47
252
1.92
4.12
1.7
1.3
—
—
—
0
0
29
130
2.28
4.04
1.3
1.4
155.00
143.68
au/ml
0.33
12
41
97
648
1.57
3.92
9.6
10.8
5.18
5.13
kpa
0.19
92
620
91
599
1.59
3.92
5.4
3.8
1.49
1.72
mmol/l
0.31
78
516
24
101
2.42
3.85
4.5
3.3
—
—
—
0
0
15
49
3.10
3.82
2.5
2.6
37.15
40.40
%
0.49
15
49
7
8
8.82
3.78
1.0
2.4
—
—
—
0
0
13
34
3.87
3.70
3.4
3.3
39.13
42.35
%
—
8
13
66
407
1.68
3.68
3.5
2.2
0.38
0.28
e6/l
0.16
66
387
85
559
1.59
3.68
1.6
1.5
—
—
—
0
0
42
227
1.90
3.63
6.0
6.6
1.53
0.84
%
0.52
42
212
28
130
2.20
3.62
4.8
3.9
—
—
—
0
0
75
482
1.62
3.57
2.6
1.8
369.99
365.37
nmol/l
0.08
68
448
171
1304
1.40
3.57
5.8
5.0
—
—
—
0
0
13
36
3.66
3.51
5.9
3.1
—
—
—
0
0
16
58
2.80
3.44
1.4
1.7
240.50
271.26
mu/l
0.32
16
47
91
618
1.54
3.43
5.4
3.8
5.85
5.90
kpa
0.20
91
599
26
120
2.21
3.42
1.1
1.2
—
—
—
0
0
11
27
4.12
3.40
1.1
1.7
—
—
—
0
0
647
6074
1.49
3.40
22.1
10.9
—
—
—
0
0
62
387
1.66
3.32
4.0
3.3
7.41
7.41
ph
0.22
53
327
47
272
1.78
3.29
3.1
3.4
—
—
—
0
0
6
7
8.63
3.27
2.7
1.1
11.00
11.79
u/l
—
6
7
44
251
1.80
3.24
5.8
6.1
1.68
1.62
%
0.13
44
235
31
159
1.99
3.14
2.8
1.8
—
—
—
0
0
5
184
0.27
3.13
27.0
10.1
—
—
—
0
0
79
533
1.54
3.08
11.2
12.3
119.80
127.31
g/l
2.31
79
520
26
126
2.10
3.06
3.4
2.3
130.65
138.68
g/l
0.63
17
101
44
256
1.76
3.05
4.5
3.0
24.02
25.12
mmol/l
1.46
44
244
49
295
1.71
3.02
1.2
1.2
—
—
—
0
0
14
52
2.72
2.90
2.3
1.6
1.29
0.90
%
—
7
36
15
58
2.62
2.89
3.1
2.6
—
—
—
0
0
6
9
6.71
2.87
1.0
1.0
—
—
—
0
0
244
2024
1.31
2.87
4.6
3.2
35.31
37.79
u/l
0.31
235
1915
22
104
2.15
2.77
4.7
3.0
6.92
7.13
mmol/l
0.18
22
97
26
132
2.00
2.73
4.3
2.8
1.37
1.55
mmol/l
0.91
26
122
16
66
2.46
2.72
1.1
1.1
—
—
—
0
0
12
40
3.03
2.70
1.3
1.1
—
—
—
0
0
152
1189
1.35
2.67
2.6
2.2
3.03
2.74
mg/l
0.78
133
1014
8
20
4.03
2.57
2.6
1.7
4.75
6.80
%
—
8
20
8
20
4.03
2.57
2.6
1.7
44.13
27.85
%
—
8
20
12
44
2.76
2.55
1.3
1.3
11.80
25.51
%
—
5
34
5
7
7.18
2.55
1.0
1.3
—
—
mmol/l
—
0
0
6
11
5.49
2.54
1.3
1.2
—
—
—
0
0
38
226
1.72
2.48
1.4
1.3
—
—
—
0
0
181
1468
1.31
2.47
3.5
3.3
1289.66
1511.08
ng/l
0.38
155
1229
31
174
1.82
2.45
1.2
1.2
249.15
251.99
u/ml
0.02
20
101
26
139
1.90
2.39
1.1
1.1
—
—
—
0
0
228
1917
1.27
2.35
2.9
2.5
0.69
0.71
ug/l
0.11
139
1039
21
106
2.01
2.27
8.4
10.7
10.95
11.85
mmol/l
0.75
21
95
21
106
2.01
2.27
8.4
10.7
103.76
105.88
mmol/l
1.52
21
95
17
79
2.18
2.26
2.2
1.3
5.80
4.36
u/ml
—
10
44
5
9
5.58
2.21
1.2
1.0
—
—
—
0
0
91
676
1.39
2.21
1.8
1.8
—
—
—
0
0
14
61
2.32
2.15
2.2
3.3
—
—
—
0
0
9
30
3.02
2.15
3.7
2.5
72.56
144.13
e6/l
—
9
30
36
222
1.65
2.10
2.4
3.4
4.82
4.73
pmol/l
0.11
31
202
16
75
2.16
2.09
1.5
1.1
—
—
—
0
0
83
613
1.40
2.09
1.2
1.2
—
—
—
0
0
47
311
1.55
2.06
7.0
4.8
117.32
104.71
ng/l
0.38
38
277
44
287
1.57
2.05
1.2
1.2
—
—
—
0
0
9
32
2.83
2.00
1.3
1.2
—
—
—
0
0
102
787
1.34
1.97
1.9
1.7
1100.45
1144.91
nmol/l
0.21
75
616
72
527
1.41
1.93
4.9
3.1
4.98
4.61
kpa
0.77
72
508
167
1384
1.27
1.91
3.5
3.3
0.03
0.01
estimate
0.28
80
466
9
34
2.67
1.87
1.4
1.2
—
—
—
0
0
565
5935
0.80
1.79
4.7
4.6
1.25
1.28
mmol/l
0.85
530
5631
13
60
2.19
1.78
1.2
1.1
—
—
—
0
0
17
88
1.95
1.76
5.9
3.9
14.05
10.98
pmol/l
0.28
17
88
245
2140
1.22
1.72
4.1
3.6
47.50
70.78
ng/l
0.43
185
1450
5
13
3.86
1.71
1.0
2.2
—
—
—
0
0
5
13
3.86
1.71
1.0
1.8
—
—
—
0
0
5
13
3.86
1.71
2.0
2.5
0.62
0.62
mmol/l
—
5
13
23
133
1.75
1.71
1.3
1.4
136.55
187.57
pmol/l
0.94
23
133
10
42
2.40
1.62
1.8
1.5
31.05
26.39
ng/l
—
10
42
536
5642
0.82
1.60
4.0
4.0
1.45
1.40
mmol/l
0.97
498
5321
19
106
1.81
1.60
4.6
4.3
3.56
2.14
mmol/l
0.86
14
55
14
70
2.02
1.60
1.7
2.2
20.57
21.83
nmol/l
0.16
14
63
14
70
2.02
1.60
1.2
1.3
—
—
—
0
0
577
6027
0.81
1.57
5.1
5.2
2.75
2.77
mmol/l
0.30
546
5724
0
44
0.00
1.51
0.0
1.2
—
0.72
—
0
27
6
21
2.87
1.51
1.3
1.3
—
—
—
0
0
253
2249
1.19
1.44
2.0
2.0
92.83
94.58
pmol/l
0.25
149
1291
9
39
2.32
1.43
15.0
3.9
0.44
1.08
index
—
9
39
680
6607
1.33
1.42
36.3
18.7
233.20
237.56
e9/l
1.23
665
6475
9
40
2.26
1.40
2.0
2.3
—
—
—
0
0
6
23
2.62
1.37
1.8
2.0
0.00
0.13
estimate
—
6
23
680
6615
1.32
1.34
36.2
18.7
4.65
4.80
e12/l
9.52
663
6474
573
5964
0.83
1.32
4.7
4.7
4.55
4.55
mmol/l
0.01
540
5689
0
41
0.00
1.31
0.0
1.0
—
8.88
—
0
9
680
6620
1.31
1.28
36.2
18.7
6.41
6.65
e9/l
2.43
664
6481
526
5506
0.85
1.24
6.1
5.8
39.00
39.03
mmol/mol
0.03
490
5249
46
610
0.74
1.20
2.6
3.2
—
—
—
0
0
46
608
0.74
1.18
2.3
2.8
—
—
—
0
0
19
118
1.63
1.15
2.4
1.2
1.59
1.40
ratio
0.75
11
63
46
605
0.74
1.15
2.3
3.2
—
—
—
0
0
12
66
1.83
1.09
1.2
1.2
—
—
—
0
0
26
177
1.49
1.09
2.7
3.2
240.23
386.60
mg/l
0.54
13
89
46
597
0.76
1.06
2.2
3.1
—
—
—
0
0
20
300
0.66
1.05
1.1
1.3
—
—
—
0
0
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
5
22
2.28
1.03
1.2
1.0
—
—
—
0
0
26
180
1.46
1.02
3.9
3.5
66.00
64.19
%
0.16
26
174
9
49
1.85
0.99
1.7
1.4
—
—
—
0
0
44
567
0.76
0.97
2.3
3.3
—
—
—
0
0
19
124
1.55
0.97
1.2
1.2
3.50
3.82
mmol/l
0.61
19
114
26
182
1.44
0.97
1.0
1.2
—
—
—
0
0
22
150
1.48
0.94
1.1
1.2
829.05
529.87
mg/l
0.61
22
141
153
1354
1.16
0.91
1.6
1.7
18.10
18.81
nmol/l
0.28
133
1177
11
63
1.76
0.90
1.3
1.5
—
—
—
0
0
6
29
2.08
0.89
1.5
1.9
—
—
—
0
0
36
470
0.75
0.89
2.2
3.5
—
—
—
0
0
22
152
1.46
0.89
9.8
3.3
3.00
2.16
index
0.38
16
92
16
103
1.57
0.88
2.3
2.1
0.85
1.11
g/l
0.44
16
82
28
204
1.39
0.86
1.1
1.1
—
—
—
0
0
108
1242
0.85
0.85
1.3
1.3
4.08
1.73
u/ml
0.44
28
384
23
162
1.43
0.85
1.7
2.6
13.60
10.48
mg/l
0.80
23
152
8
45
1.79
0.84
1.5
1.1
—
—
—
0
0
26
188
1.40
0.84
2.8
2.1
—
—
—
0
0
12
190
0.63
0.84
4.4
4.5
1.34
1.50
mmol/l
0.54
12
185
22
155
1.43
0.82
1.4
1.1
—
—
—
0
0
31
399
0.77
0.72
3.4
5.1
—
—
—
0
0
30
230
1.32
0.70
2.3
2.6
213.80
623.90
ug/l
1.37
30
223
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
258
2759
0.90
0.68
3.1
2.9
—
—
—
0
0
407
3886
1.10
0.67
3.5
3.0
14.91
14.84
pmol/l
0.20
368
3557
17
237
0.71
0.67
3.1
5.3
—
—
—
0
0
11
167
0.65
0.66
1.0
1.1
—
—
—
0
0
12
78
1.55
0.66
1.8
2.4
10.90
11.02
%
0.03
12
78
30
380
0.78
0.63
2.5
2.5
26.97
13.25
au/ml
—
6
54
5
30
1.67
0.61
3.8
5.8
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
3.74
—
0
6
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
21
158
1.34
0.57
1.9
1.6
—
—
—
0
0
6
36
1.67
0.56
1.3
1.6
—
22.88
—
0
5
17
124
1.38
0.56
1.2
1.2
—
—
—
0
0
13
90
1.45
0.55
1.0
1.1
—
—
—
0
0
527
5414
0.91
0.55
4.6
4.5
5.99
6.00
mmol/l
0.05
479
5035
6
37
1.63
0.55
1.0
1.4
5.60
6.82
u/l
—
6
31
15
204
0.73
0.53
1.9
1.8
15.40
17.69
u/ml
—
7
65
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
469
4549
1.08
0.48
3.8
3.4
58.04
48.30
u/l
1.29
452
4359
18
232
0.77
0.46
1.2
1.5
—
—
—
0
0
40
338
1.19
0.46
6.3
6.1
—
—
—
0
0
11
77
1.43
0.45
1.7
2.8
—
—
—
0
0
75
669
1.13
0.45
2.6
3.2
4.22
4.31
e9/l
0.08
60
591
12
86
1.40
0.44
1.2
1.2
—
—
—
0
0
65
733
0.88
0.44
1.2
1.3
3.71
6.41
u/ml
0.60
17
304
240
2277
1.08
0.43
3.9
2.7
186.54
164.31
ug/l
0.82
221
2134
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
0.83
—
0
9
5
34
1.47
0.40
1.2
1.4
0.56
0.51
e9/l
—
5
34
65
726
0.89
0.39
3.8
3.4
249.61
153.34
ug/g
1.20
58
618
32
272
1.18
0.36
1.2
1.7
—
7.59
—
0
12
9
71
1.27
0.36
1.2
1.1
241.22
265.97
mg/l
—
9
65
198
2085
0.93
0.36
3.7
4.0
9.18
9.14
mmol/l
0.04
163
1826
5
76
0.66
0.36
1.4
5.1
—
—
—
0
0
14
108
1.30
0.35
1.1
1.1
3.23
16.36
au/ml
—
6
45
118
1098
1.09
0.34
4.0
3.7
441.89
738.48
ng/l
0.75
94
828
81
740
1.11
0.34
1.3
1.4
371.43
317.63
titre
0.20
14
135
20
164
1.23
0.33
1.1
1.1
—
—
—
0
0
7
52
1.35
0.31
1.1
1.4
—
—
—
0
0
7
53
1.32
0.31
1.7
1.2
—
—
—
0
0
7
53
1.32
0.31
1.1
1.3
7.92
6.86
g/l
—
7
35
7
53
1.32
0.31
1.1
1.3
2.75
3.25
g/l
—
7
35
7
53
1.32
0.31
1.1
1.3
0.30
0.38
g/l
—
7
34
7
54
1.30
0.30
1.6
1.1
—
—
—
0
0
7
54
1.30
0.30
1.0
1.1
272.86
286.75
mg/l
—
7
44
77
709
1.10
0.29
1.6
1.5
—
—
—
0
0
7
57
1.23
0.29
1.0
1.2
55.71
44.03
mg/l
—
7
45
10
76
1.32
0.28
1.1
1.1
—
—
—
0
0
78
723
1.09
0.26
1.6
1.7
3.81
3.61
mmol/l
0.50
48
488
12
96
1.25
0.24
1.2
1.4
—
—
—
0
0
77
825
0.93
0.24
1.3
1.3
13.10
22.43
iu/ml
2.81
20
227
32
358
0.89
0.23
1.2
1.1
0.92
0.72
ratio
—
5
34
504
4963
1.05
0.22
4.2
3.8
1.81
1.89
mu/l
0.77
459
4581
7
95
0.73
0.22
1.0
1.3
—
—
—
0
0
84
894
0.93
0.22
1.2
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
69.82
—
0
11
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
7.4
—
8.17
—
0
10
0
13
0.00
0.21
0.0
1.1
—
36.98
—
0
13
34
376
0.90
0.20
1.1
1.1
1.34
1.41
g/l
1.18
34
376
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
6
49
1.23
0.20
1.0
1.0
1535.83
1500.08
miu/ml
—
6
49
19
165
1.16
0.19
1.1
1.1
—
—
—
0
0
35
383
0.91
0.18
1.2
1.2
0.97
0.93
g/l
0.44
35
383
13
110
1.19
0.17
1.1
1.3
34.68
15.27
u/l
0.37
13
95
5
66
0.76
0.17
1.2
1.3
—
—
nmol/l
—
0
0
5
68
0.73
0.17
2.6
2.6
11.60
10.61
mmol/l
—
5
68
41
379
1.09
0.16
2.3
1.9
0.00
0.00
estimate
-0.00
12
94
11
92
1.20
0.16
1.0
1.2
—
—
—
0
0
130
1254
1.04
0.15
3.2
3.3
1.02
1.02
kg/l
1.06
87
784
37
342
1.09
0.15
2.4
2.2
6.15
6.09
ph
0.16
24
218
115
1110
1.04
0.13
1.6
1.4
2.53
2.65
g/l
0.25
79
760
22
200
1.10
0.12
1.3
1.3
195.00
173.78
miu/ml
—
9
77
47
444
1.06
0.12
1.5
1.8
0.46
0.34
mg/l
0.50
25
251
90
934
0.96
0.12
1.4
1.5
—
—
—
0
0
22
201
1.10
0.11
2.2
1.8
5.30
6.92
iu/ml
—
7
51
5
60
0.83
0.08
8.4
11.9
0.56
0.57
mmol/l
—
5
54
6
72
0.83
0.07
1.2
1.4
—
0.37
—
0
9
24
225
1.07
0.07
1.7
2.0
0.00
3.20
estimate
—
9
79
12
108
1.11
0.07
1.3
1.2
—
—
—
0
0
37
354
1.05
0.06
8.3
8.5
24.29
24.32
mmol/l
0.02
37
338
54
522
1.04
0.06
1.4
1.4
—
—
—
0
0
240
2422
0.99
0.04
2.0
1.9
1.60
1.51
mmol/l
0.73
202
2105
177
1790
0.99
0.04
4.4
4.6
8.48
10.60
mg/mmol
0.34
115
1215
14
149
0.94
0.03
5.0
1.4
1.31
1.17
g/l
0.85
14
141
45
440
1.02
0.02
1.1
1.1
—
—
—
0
0
14
148
0.94
0.02
5.0
1.3
0.27
0.24
g/l
0.62
14
141
102
1030
0.99
0.02
1.8
1.8
429.61
40639685.07
pmol/l
1.24
83
876
41
417
0.98
0.01
1.2
1.2
—
—
—
0
0
16
156
1.03
0.00
1.6
2.4
57.47
116.69
ug/min
0.74
11
91
23
226
1.02
0.00
1.0
1.1
—
—
—
0
0
175
1747
1.00
0.00
3.6
3.8
47.02
65.02
mg/l
0.74
126
1209
224
2237
1.00
0.00
2.8
2.4
72.46
71.66
nmol/l
0.15
205
2059
24
239
1.00
0.00
1.5
1.6
—
—
—
0
0
24
241
1.00
0.00
1.2
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
282.25
—
0
8
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
307.00
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
13.77
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
2.12
—
0
9
0
9
0.00
-0.00
0.0
1.1
—
0.82
—
0
9
5
51
0.98
-0.00
1.2
1.1
9039.00
105222.28
e6/l
—
5
39
0
9
0.00
-0.00
0.0
1.4
—
15.00
—
0
9
7
71
0.99
-0.00
1.3
1.5
40.57
96.08
mu/l
—
7
58
0
6
0.00
-0.00
0.0
1.0
—
0.05
—
0
6
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.3
—
0.67
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.3
86.20
86.19
umol/l
—
5
52
5
55
0.91
-0.00
3.8
2.9
94.36
17.19
mg/l
—
5
48

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: C3_TESTIS_WIDE – Malignant neoplasm of testis, including Hilmo

GWS hits: 4

This endpoint is excluded (different definition than used in FinnGen).